Omid Omidvar MD
Movement Disorder, Neuroimmunology/Multiple Sclerosis, Dementia & Geriatrics
Physician
Join to View Full Profile
3747 Worsham Ave.Suite 100Long Beach, CA 90808
Phone+1 562-430-4513
Fax+1 562-430-7718
Dr. Omidvar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Omid Omidvar is a neurologist in Long Beach, CA and is affiliated with multiple hospitals in the area, including MemorialCare, Long Beach Memorial Medical Center and Los Alamitos Medical Center. He received his medical degree from Other and has been in practice 25 years. He also speaks multiple languages, including Farsi and French. He specializes in movement disorder, neuroimmunology/multiple sclerosis, and dementia & geriatrics and is experienced in general neurology, autonomic disorders, stroke, migraine disorders, and multiple sclerosis.
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Neurology, 1995 - 1998
Kirk Kerkorian School of Medicine at UNLVResidency, Internal Medicine, 1994 - 1995
OtherClass of 1992, MD
Certifications & Licensure
CA State Medical License 1996 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2017-2019
- CMS Meaningful Use Stage 1 Certification Capella, Acurus Solutions, Inc., 2012, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy Start of enrollment: 2010 Jun 01
- AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 8 citationsDouble blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia.David R Lynch, Katherine D Mathews, Susan Perlman, Theresa Zesiewicz, Sub Subramony
Journal of Neurology. 2023-03-01 - 146 citationsPreclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.Danna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, Jennifer C Sasaki, René Meisner
Science Translational Medicine. 2022-06-08 - 224 citationsSafety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinica...Joseph Jankovic, Ira J. Goodman, Beth Safirstein, Tonya K. Marmon, Dale Schenk
JAMA Neurology. 2018-10-01
Press Mentions
Failure of Once-Promising Alzheimer’s Drug Reinforces Doubts About Amyloid BetaApril 18th, 2019
Alzheimer’s: Local Physicians Brainstorm Preventative MeasuresJune 4th, 2018- As Prevalence of Alzheimer’s Disease Rises with Aging Population, Researchers Seek Therapeutic StrategiesNovember 23rd, 2015
Professional Memberships
- Member
Other Languages
- Farsi, French
External Links
- Southland Neurologic Associateshttp://www.myneurologists.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
